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Comparative genomicsType XVIII collagen is a component of basement membranes, and expressed prominently in the eye, blood
vessels, liver, and the central nervous system. Homozygous mutations in COL18A1 lead to Knobloch
Syndrome, characterized by ocular defects and occipital encephalocele. However, relatively little has been
described on the role of type XVIII collagen in development, and nothing is known about the regulation of its
tissue-speciﬁc expression pattern. We have used zebraﬁsh transgenesis to identify and characterize cis-
regulatory sequences controlling expression of the human gene. Candidate enhancers were selected from
non-coding sequence associated with COL18A1 based on sequence conservation among mammals. Although
these displayed no overt conservation with orthologous zebraﬁsh sequences, four regions nonetheless acted
as tissue-speciﬁc transcriptional enhancers in the zebraﬁsh embryo, and together recapitulated the major
aspects of col18a1 expression. Additional post-hoc computational analysis on positive enhancer sequences
revealed alignments between mammalian and teleost sequences, which we hypothesize predict the
corresponding zebraﬁsh enhancers; for one of these, we demonstrate functional overlap with the
orthologous human enhancer sequence. Our results provide important insight into the biological function
and regulation of COL18A1, and point to additional sequences that may contribute to complex diseases
involving COL18A1. More generally, we show that combining functional data with targeted analyses for
phylogenetic conservation can reveal conserved cis-regulatory elements in the large number of cases where
computational alignment alone falls short.
© 2009 Elsevier Inc. All rights reserved.Introduction
Collagens are collectively the most abundant component of
extracellular matrix (Gelse et al., 2003). Although collagens are
universally present in human tissues, some types have a constrained
pattern of expression. Collagen type XVIII is a nonﬁbrillar collagen
that, together with collagen XV, comprises the subgroup of multi-
plexins (multiple triple helix domain with interruption) (Rehn and
Pihlajaniemi, 1994; Saarela et al., 1998b). COL18A1 maps to HSA
21q22.3 and its 43 exons span 108.5 kb (Oh et al., 1994). Three
isoforms are generated by the use of two promoters and alternative
splicing in the third exon (Rehn et al., 1996; Saarela et al., 1998b;
Suzuki et al., 2002). The short isoform (NC11–303) is transcribed
from the ﬁrst promoter, upstream of exon 1, and contains exons 1, 2,
and 4–43. The intermediate (NC11–493) and long (NC11–728)elopmental Biology, University
B II/III 1213, Philadelphia, PA
mental Biology, University of
4, USA.
ll rights reserved.forms are transcribed from the second promoter, upstream of exon
3, and differ by an internal splice site within exon 3. Although
collagen XVIII is a component of vessel walls and almost all
basement membranes (Halfter et al., 1998), the three isoforms
have distinct patterns of expression. The short isoform is expressed
in kidney, retina, placenta and human fetal brain (Saarela et al.,
1998a; Sertie et al., 2000), whereas the intermediate and long
isoforms have their highest expression levels in liver and lung,
respectively (Saarela et al., 1998a; Suzuki et al., 2002). Three
isoforms of collagen XVIII are also present in mice, with tissue-
speciﬁc expression pattern apparently similar to human (Muragaki
et al., 1995). Col18a1 expression is important for retinal pigment
epithelium and hyaloid vessel maintenance, since mice lacking
collagen XVIII show defects in these tissues (Fukai et al., 2002;
Hurskainen et al., 2005). However, its expression has not been
examined by whole embryo in situ hybridization during mouse
embryogenesis. In zebraﬁsh embryos from segmentation to hatch-
ing, col18a1 is expressed in pronephric ducts, otic vesicle, forebrain,
tectum, epidermis, spinal cord, pectoral ﬁn bud, myoseptum and
notochord (Haftek et al., 2003; Thisse et al., 2001). Expression of
col18a1 after hatching, or at any stage in liver, gut endoderm, or
blood vessels has not been described.
Table 1
Genome coordinates of ampliﬁed human sequences.
Amplicon Coordinatesa Size (bp)
CNSp −96.9 45551381–45552562 1181
CNSv −97.8 45551403–45551670 267
CNSp −80.5 45568753–45568986 233
CNSv −78.7 45570340–45570794 454
CNSp −72.2 45575491–45577292 1801
CNSv −64.9 45584370–45584612 242
CNSv −52.9 45596190–45596573 383
CNSp −47.4 45601821–45602101 280
CNSv −40.8 45608418–45608709 291
CNSv −38.0 45611223–45611488 265
CNSp −28.7 45620217–45620766 549
CNSv −26.7 45622453–45622740 287
CNSv +0.6 45650150–45650576 427
CNSv +3.1 45652238–45652652 414
CNSv +25.5 45674812–45675078 266
CNSp +47.8 45694764–45697397 2633
CNSp +51.7 45700781–45701305 524
CNSv +51.7 45700938–45701276 338
CNSv +64.8 45714075–45714384 309
CNSp +65.7 45714053–45715256 1203
a All sequences are on human chromosome 21, and coordinates are given relative to
the March 2006 assembly.
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play a role in diverse biological processes. Endostatin, a 20 kDa C-
terminal proteolytic product of collagen XVIII, acts as an inhibitor of
angiogenesis and tumor growth (Abdollahi et al., 2004; Marneros and
Olsen, 2001; Marneros and Olsen, 2005; O'Reilly et al., 1997). Collagen
XVIII also has two N-terminal domains: trombospondin-1 like, of
unknown function; and frizzled, a cleaved fragment related to the
frizzled family of cell surface Wnt receptors (Elamaa et al., 2003;
Quelard et al., 2008). The zebraﬁsh diwanka gene, required for motor
axon guidance, encodes a lysyl glycosyltransferase whose main target
relevant to axon guidance is thought to be myotomal collagen XVIII
(Schneider and Granato, 2006). The C. elegans homologue of col18a1
is also required for axon guidance (Ackley et al., 2001), suggesting an
ancient conserved role for collagen XVIII in neural development.
Further insights into COL18A1 function have arisen from the
ﬁnding that null mutations in COL18A1 cause Knobloch Syndrome
(KS), an autosomal recessive disorder characterized by high myopia,
vitreoretinal degeneration with retinal detachment, macular abnor-
malities, and occipital encephalocele, which is the pathognomonic
feature of the syndrome (Sertie et al., 2000; Suzuki et al., 2002). Inter-
and intra-familial clinical variability is present, but all patients have
ocular abnormalities that usually lead to bilateral blindness. Some
patients also display generalized hyperextensibility of the joints,
unilateral duplicated renal collecting system, epilepsy, and evidence
of altered neuronal migration (Passos-Bueno et al., 2006; Suzuki et al.,
2002). Such variability may reﬂect the complexity and pleiotropy of
COL18A1 function. Alterations in collagen XVIII levels have been
associated with complex disorders such as hepatocarcinoma (Arme-
lin-Correa et al., 2005; Hu et al., 2005; Musso et al., 2001a; Musso et
al., 2001b), obesity (Errera et al., 2008) among others (Iizasa et al.,
2004; Lourenco et al., 2006), and therefore, the understanding of its
regulatory control might contribute to new strategies for treatment of
these disorders. To date, only the function of the proximal second
promoter of COL18A1 has been examined, and more distant cis-
regulatory sequences have not been described (Armelin-Correa et al.,
2005).
Ascribing function to non-coding sequence is a primary challenge
arising from the sequencing of the human genome (Feingold and
Consortium, 2004). Functional non-coding sequences can activate
transcription and participate in control of spatiotemporal gene
expression and also play a role in diseases (Antonellis et al., 2008;
Grice et al., 2005). The availability of additional genome sequences
has created the opportunity for cross species alignment and the
determination, with the help of computational tools, of conserved
sequences between genomes (Ahituv et al., 2004; Nobrega and
Pennacchio, 2004; Poulin et al., 2005; Woolfe et al., 2005). The
hypothesis that functional elements are under negative selection
suggests that highly conserved sequences will likely be functional,
although in reality the correlation between degree of conservation
and function for cis-regulatory elements is unclear. We have
previously shown that moderate conservation, conﬁned to mamma-
lian lineages, is often predictive of function conserved to teleosts,
making the zebraﬁsh a feasible model to test function of many
mammalian regulatory sequences (Antonellis et al., 2008; Fisher et al.,
2006a; Pashos et al., 2008).
We have employed zebraﬁsh transgenesis to examine conserved
non-coding sequences associated with COL18A1 for regulatory
function. We identiﬁed four regions that, taken together, recapitulate
the major features of col18a1 expression in the zebraﬁsh embryo,
despite lack of overt conservation with orthologous zebraﬁsh se-
quences. Through subsequent, targeted sequence comparisons using
additional algorithms, we deﬁned a zebraﬁsh enhancer sharing
substantial function with one of the human enhancers. This general
strategy should help in the identiﬁcation of additional orthologous
enhancers across species, in cases where broad sequence comparisons
fall short.Methods
Identiﬁcation of conserved non-coding sequences
A region encompassing COL18A1 was chosen for analysis, starting
from 100 kb upstream of the translation start site of the short isoform
to the beginning of SLC19A1, corresponding to genome coordinates
chr21: 45527766–45760000. Conserved non-coding sequences were
selected using two algorithms: the human and orthologous mouse
regions were aligned using the VISTA browser (conservation para-
meters ≥75%, ≥100 bp); and the algorithm PhastCons was used as
available on the UCSC genome browser, incorporating 17 vertebrate
genome sequences. Conserved sequences were designated either
CNSv⁎ or CNSp⁎, selected fromVista or PhastCons, respectively, where ⁎
denotes distance in kb and position (+ or−) relative to the translation
start site of the short isoform. The genome coordinates of all human
sequences selected for analysis are given in Table 1. The coordinates of
the tested zebraﬁsh sequence were chr9: 35866596–35867693 on the
July 2007 assembly.
In situ hybridizations
Zebraﬁsh embryos were collected from wild-type matings at
stages from prim-6, or 24 h post fertilization (hpf) to 5 days post
fertilization (dpf) and ﬁxed in 4% paraformaldehyde. Wild-type
mouse embryos at 9.5 days post copulation (dpc) were collected
and ﬁxed in 4% paraformaldehyde. A partial cDNA clone of zebraﬁsh
col18a1 (plasmid Cb371; GenBank accession # CB923547) was used
to amplify a riboprobe templatewith primers: F-GAATTCCTGGCACTG-
GATCA and R-TAATACGACTCACTATAGGGAGTGGAAGCACATGAAG-
TCTGC. For slc19a1 and pofut2, we ampliﬁed the riboprobe templates
from cDNA of 1 dpf zebraﬁsh embryos with the following primers:
slc19a1 F GTTTATCACACCGTACCTGCTCAGT and R TAATACGACTCAC-
TATAGGGAGCAAACTCCAAAGTCTTAAACTAGGC; pofut2 F ATCTAGTA-
ACTCGTCGTCTGCTTCA and R TAATACGACTCACTATAGGGAGGTAAGG-
GCCACCTTTAGCACT. The riboprobe template for mouse in situ
hybridizations was generated by PCR ampliﬁcation from mouse
cDNA with primers: F-AGTTCCACATCACCACAGTTCCTAT and R-TAA-
TACGACTCACTATAGGGAGCATGTCTCACAGTAACTCTCCATCA. Digoxy-
genin labeled probes were synthesized with T7 RNA polymerase.
Whole-mount in situ hybridizations were performed according to
standard protocols (Thisse and Thisse, 2008).
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All CNSs were ampliﬁed by PCR from human genomic DNA with
high ﬁdelity DNA polymerase, and cloned into the Tol2 transposon
based vector pGWcfosEGFP as previously described (Fisher et al.,
2006b). Fish were cared for following standard protocols (Kimmel et
al., 1995; Westerﬁeld, 2000). Each construct was injected in at least
two separate experiments, and mosaic expression of EGFP analyzed
in a minimum of 200 embryos. Embryos were screened from 24 hpf
to 5 dpf using a Zeiss V12 Stereomicroscope, and imaged with
AxioVision 4.5 software. For those constructs regulating a consis-
tent expression pattern, embryos were raised to adulthood and their
progeny examined for expression after germline transmission. All
constructs were examined in at least three independent transgenic
lines, and among these each showed consistent expression.
Post-hoc computational analysis
Additional computational analysis was performed with MultiPip-
maker (Schwartz et al., 2003), using default parameters, as outlined in
the Results section. We also used the glocal alignment program
Shufﬂe-LAGAN, as implemented through the VISTA web server; for
alignments other than human to mouse, the parameters were relaxed
to 50% identity over 100 bases.
Results
Col18a1 has a complex pattern of expression in zebraﬁsh embryos
To obtain a detailed picture of col18a1 expression during zebraﬁsh
embryogenesis, we performed whole embryo in situ hybridization at
stages from 24 hpf to 5 dpf, with a probe designed to detect all
isoforms. In agreement with previous descriptions (Haftek et al.,
2003; Thisse et al., 2001), we observed col18a1 expression at 24 hpf in
epidermis, pronephric ducts, spinal cord, somite boundaries (myo-
septum), otic vesicle, forebrain, and eye primordium (Fig. 1A and dataFig. 1. Zebraﬁsh col18a1 displays a complex and dynamic development expression pattern. E
2 dpf (B); and 3 dpf (C–E). Dynamic expression was seen in neutral structures including spin
(A, E); myospetum (A); epidermis (A, B); otic vesicle (B); pharyngeal arches (B); craniofacia
gut endothelium (E). Abbreviations used in all ﬁgures: BV (blood vessels), Ca (cartilage), FB
arches), PD (pronephric duct), PF (pectoral ﬁn), Pr (pronephros), Re (retina), RPE (retinalnot shown). At 2 dpf col18a1 showed a similar pattern, with additional
expression seen in anterior notochord, branchial arches, and pectoral
ﬁn bud (Fig. 1B). In the eyes, col18a1 expression was primarily
conﬁned to retinal pigment epithelium. By 3 dpf expression was also
seen in gut, cartilage and blood vessels (Figs. 1C–E), and at 4–5 dpf in
the liver (data not shown).
Col18a1 expression in whole mouse embryos
To determine if Col18a1 expression inmouse is similar to zebraﬁsh,
we carried out in situ hybridizations on 9.5 dpc whole mouse
embryos. Col18a1 was expressed in epidermis, otic vesicle, retinal
primordium, cranial blood vessels, aorta, forebrain, brain ventricles,
and pharyngeal arches (Fig. 2). This overall pattern is similar to
zebraﬁsh, with expression in retina, otic vesicle and blood vessels
observed in both organisms.
Selection of conserved non-coding sequences (CNS) for functional
analysis
To select conserved non-coding sequences for analysis, we
examined a total of 232 kb, corresponding to intronic sequences of
COL18A1 and 100 kb upstream of the ﬁrst exon (Fig. 3). We identiﬁed
12 CNSs based on a pair-wise alignment between human and mouse
loci (Vista browser, ≥75% identity and ≥100 bp) termed CNSv, and
8 CNS based on a multiple alignment with orthologues in mammals
(PhastCons), termed CNSp (Fig. 3; Table 1). Twelve CNSs are localized
upstream of the COL18A1 translation start site and eight CNSs are
located in intronic regions. Using either algorithm, the non-coding
sequences associated with human COL18A1 failed to show detectable
conservation with orthologous regions in teleosts.
CNSs regulate reporter gene expression consistent with zebraﬁsh col18a1
To test the regulatory function of the identiﬁed CNSs, each se-
quence was cloned into a vector containing the heterologous minimalxpression of col18a1was detected by whole embryo in situ hybridization at 24 hpf (A);
al cord (A) and tectum (B). Expression was also seen in pronephric duet and pronephros
l cartilages and blood vessels (C); retinal pigment epithelium (D); pectoral ﬁns (E); and
(forebrain), Gu (gut endothelium), My (myoseptum), OV (otic vesicle), PA (pharyngeal
pigment epithelium), SC (spinal cord), Te (tectum).
Fig. 2. Mouse Col18a1 shows conserved development expression pattern. In situ hybridization for Col18a1 was performed on whole mouse embryos at 11.5 dpc. Expression was
observed in forebrain, pharyngeal arches, and spinal cord (A), and in retina, blood vessels, otic vesicle, and aorta (B, C).
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in ≥200 zebraﬁsh embryos at the 2-cell stage, which were screened
for mosaic EGFP expression daily to 5 dpf and compared with
endogenous col18a1 expression. We also analyzed by in situ
hybridization the expression patterns of the zebraﬁsh orthologues
of the neighboring genes of COL18A1 (POFUT2 and SLC19A1). Neither
showed similarity with the col18a1 expression, or with the analyzed
transgenic constructs (data not shown).
Of the 20 constructs analyzed, 5 regulated transcription con-
sistent with endogenous col18a1 expression in zebraﬁsh. Three of
the CNSs are localized upstream of the translation start site (CNSv
−97.8; CNSp −96.9; CNSv −78.7) and two in intronic regions of
COL18A1 (CNSp +47.8; CNSv +64.8). Fish carrying these constructs
were established as transgenic lines and studied in detail in non-
mosaic embryos. Initially, embryos from at least three independent
founders were examined for each construct, and analysis was
carried out on one representative line. As detailed in the Supple-
mental Data, in most cases the independent lines were indistin-
guishable in pattern; where there was variability, the lines still
shared a dominant expression pattern (Supplemental Figs. 1–4). The
tissue-speciﬁc expression pattern regulated by each CNS is des-
cribed below.
CNSv −97.8/CNSp −96.9 (retina and pronephric ducts)
CNSv −97.8 and CNSp −96.9 were identiﬁed using the Vista and
PhastCons algorithms, respectively, and overlapped substantially.Fig. 3. In silico selection of conserved non-coding sequences associated with COL18A1. The
conservation peaks from Vista Browser (mouse vs. human) are illustrated at the top, an
transgenesis based on the Vista analysis (CNSv) and those selected based on the PhastConsTransgenes containing the two elements led to indistinguishable
patterns of egfp expression. At 24 hpf, strong expression was seen in
retina, tectum, otic vesicle, pharyngeal arches and pronephric ducts
(Figs. 4A–D). Expression in pronephric ducts, retina and tectum was
transient, and no longer detectable by 2 dpf (Figs. 4E and F). After 2
dpf, EGFP was expressed in cartilage of the craniofacial skeleton,
pectoral ﬁns, and otic capsule.
CNSv −78.7 (endoderm derivatives)
CNSv −78.7 regulated expression in the brain and pharyngeal
arches at 24 hpf (Fig. 5A), but at later stages expression in the brain
decreased (Fig. 5B). Cartilage expression was observed clearly from 2
to 5 dpf (Figs. 5B, D–F). In addition, expression was observed in gut
endoderm at 5 dpf (Fig. 5C).
CNSp +47.8 (blood vessels and retinal pigment epithelium)
Blood vessels in adult tissues are a prominent site of COL18A1
expression. A single element, CNSp +47.8, led to expression in blood
vessels in the embryo. Beginning at 1 dpf, expression was seen in the
heart, otic vesicle and pharyngeal arches (Figs. 6A, B) and at 2 dpf in
blood vessels of the eyes and pharyngeal arches (Fig. 6C). At 3dpf EGFP
expression was observed widely in blood vessels, including the dorsal
aorta, dorsal ciliary vein, intersegmental vessels, and craniofacial
vessels (Figs. 6D–F). In addition, CNSp+47.8 drove EGFP expression in
cartilage, retinal pigment epithelium, and ﬂoor plate (Fig. 6D).interval containing COL18A1 is shown as represented in the UCSC Genome Browser,
d PhastCons Conserved elements shown at the bottom. The sequences selected for
analysis (CNSp) are displayed as custom tracks, in red and blue respectively.
Fig. 4. Overlapping upstream sequences regulate similar patterns of EGFP expression in zebraﬁsh embryos. Embryos transgenic for either CNSv−97.8 or CNSp−96.9 constructs had
EGFP expression at 24 hpf in forebrain, retina, tectum, otic vesicle, and pronephric duct (A–D), and transiently in somites (A, C). At 3 dpf, EGFP was expressed in cartilage of the head,
pectoral ﬁns, and otic vesicle (E, F).
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At 24 hpf, CNSv +64.8 transgenic embryos showed EGFP
expression in the tectum, otic vesicle, pectoral ﬁn buds, pharyngeal
arches, and spinal cord (Fig. 7A, B). The early nervous system
expressionwas transient; at 2 dpf, expressionwas seen inmyoseptum
(Fig. 7C) and cartilage (Fig. 7D), at 3 dpf in cartilage (Fig. 7E), and by 5
dpf in liver (Fig. 7F).Fig. 5. An upstream enhancer sequence regulates expression in brain, cartilage, and gut. Em
and pharyngeal arches (A). Later expression was seen in craniofacial, otic capsule, and pector
gut endothelium at 5 dpf (C).Functional differences in overlapping elements
We identiﬁed three pairs of CNSs independently by VISTA and
PhastCons that partially overlapped. As shown in Fig. 4, CNSv −97.8
and CNSp −96.9 (267 and 1181 bp, respectively) regulated
indistinguishable patterns of expression. A second pair of elements,
CNSv +51.7 and CNSp +51.7 (338 and 524 bp, respectively) regu-
lated no detectable expression in transgenic embryos. Interestingly, abryos transgenic for CNSv−78.7 constructs had EGFP expression at 24 hpf in the brain
al ﬁn cartilages at 3 dpf (B, D), 4 dpf (E) and 5 dpf (F). EGFP expression was also seen in
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pectively), showed functional divergence. While CNSv +64.8 regu-
lated tissue-speciﬁc expression (Fig. 7), CNSp +65.7 did not regulate
expression, suggesting that the additional sequence present in the
longer CNS contains a negative regulatory element.
Post hoc analysis reveals human–zebraﬁsh sequence similarities
The initial analysis to identify conserved non-coding regions,
performed with VISTA and PhastCons, failed to detect any conser-
vation extending from human to teleosts. We subsequently
performed alignment of the entire Col18a1 interval, from human,
mouse, chicken, stickleback, and zebraﬁsh, using MultiPipmaker
(Elnitski et al., 2005; Schwartz et al., 2003). Pipmaker is designed to
detect alignments with high sensitivity, but does not calculate
signiﬁcance or likelihood of conservation. Therefore, it is more likely
to return false positive alignment results, but in the setting where
functional sequences have already been identiﬁed, we hypothesized
that it might be better able to detect orthologous zebraﬁsh enhancer
elements. Indeed, regions of sequence similarity were detected either
within or very near several of the tested regions, including sequences
adjacent to two of the functional enhancers, CNS −96.9 and +47.8
(data not shown). However, these alignments as well as many
additional ones within the interval were of repetitive sequences,
likely to be spurious.Fig. 6. Blood vessels expression of COL18A1 is mediated by an intronic enhancer element. Emb
(B) dpf in the pharyngeal arches and heart (A, B), and at 3 dpf in blood vessels and cartilage
aorta and other blood vessels of the trunk (E, F).We performed additional alignments from the above species with
the Shufﬂe-LAGAN algorithm (Brudno et al., 2003), incorporated as
part of the VISTA browser site (Frazer et al., 2004). Shufﬂe-LAGAN is
among the class of “glocal” alignment programs, integrating features of
both global and local applications, and is particularly designed to
detect sequence similarities despite small-scale rearrangements such
as inversions, translocations, duplications, and deletions. We per-
formed an alignment of intergenic sequences from human, mouse,
chicken, stickleback, and zebraﬁsh, centered around exons 2 and 3 and
including the positive enhancers CNS +47.8 and +64.8; for align-
ments more distant than human to mouse, the standard parameters
were relaxed to 50% identity over 100 bp. We detected alignments of
non-coding sequences extending to teleosts, with stickleback for CNS
+64.8 and with zebraﬁsh for CNS +47.8 (Fig. 8A). Alignments of
upstream regions failed to detect similarity beyond ∼40 kb upstream
of the human gene, despite the presence of two positive enhancer
sequences farther upstream. However, there is a break in conserved
synteny between mammals and teleosts upstream of COL18A1 (the
adjacent annotated genes are POFUT2 and cdtsp1 respectively), and
associated rearrangements may obscure alignments.
Identiﬁcation of an orthologous zebraﬁsh enhancer
A portion of the alignment between zebraﬁsh and CNS +47.8
was repetitive sequence, with many close matches in the both theryos transgenic for the CNSp+47.8 constructs displayed EGFP expression at 1 (A) and 2
of the pharyngeal arches (C, D), in the retina pigment epithelium (D), and in the dorsal
Fig. 7. A second intronic enhancer mediates expression in liver and other tissues. CNSv +64.8 regulated EGFP expression at 24 hpf in tectum, otic vessel, pharyngeal arches (A), and
spinal cord (B), and at 2 dpf in myoseptum (C). Expression was also seen in craniofacial and pectoral ﬁn cartilage at 2 (D) and 3 (E) dpf, and in liver at 5 dpf (F).
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repetitive portion of the aligned sequence (zCNS +88) and
evaluated its regulatory function in mosaic transgenic zebraﬁsh. It
was a strong positive transcriptional enhancer, with expression at
24 hpf in epidermis and skeletal muscle, frequent sites of spurious
expression in mosaic analysis. Interestingly, the human CNS +47.8
similarly displayed a high level of background expression in mosaic
G0 embryos (data not shown), although the expression in G1
established lines showed a dominant tissue-speciﬁc pattern (Figs. 6
and S3). We also observed clear patterns of tissue-speciﬁc egfp
expression regulated by the zebraﬁsh sequence in G1 established
lines. At 1 dpf, there was strong expression in heart endothelial cells
and otic vesicle (Fig. 8B). In addition, we observed egfp-expression
in the ﬂoorplate and in aorta (Fig. 8C), pharyngeal arch cartil-
age (Figs. 8D, E) and craniofacial blood vessels (Fig. 8F, G), demons-
trating substantial functional overlap with the human CNS +47.8
enhancer.
Discussion
Our analysis of zebraﬁsh col18a1 demonstrated a complex and
dynamic pattern of expression during embryogenesis. In agreement
with previous descriptions (Haftek et al., 2003; Thisse et al., 2001),
we observed expression in pronephric ducts, otic vesicle, epidermis,
spinal cord, notochord, forebrain, and the tectum in the ﬁrst 3 days.
We also observed transient expression in the retina at 24 hpf,
although eye expression at later stages was limited to the retinal
pigment epithelium. Importantly, at later stages we describe
expression in cartilage, blood vessels, gut, and liver, not previously
reported in zebraﬁsh but consistent with expression in other
species (Carvalhaes et al., 2006; Fukai et al., 2002; Halfter et al.,
1998; Marneros and Olsen, 2003). Although mouse Col18a1
expression was known for some speciﬁc tissues (Carvalhaes et al.,
2006; Fukai et al., 2002; Muragaki et al., 1995), its overall pattern
of expression in mouse embryogenesis had not been described.
We show that the expression at 9.5 dpc is largely similar to zebra-
ﬁsh at comparable stages. The substantial conservation of expres-
sion pattern across vertebrates argues that the regulatory mechan-isms governing Col18a1 expression are likely to be conserved as
well.
We employed transgenesis in the zebraﬁsh to functionally
evaluate potential enhancer elements regulating COL18A1 tran-
scription. Out of 20 sequences tested, we identiﬁed ﬁve non-coding
elements associated with the human gene, from four independent
regions, that regulate transcription consistent with endogenous
zebraﬁsh col18a1. Together, the expression patterns controlled by
these enhancer regions constitute the major components of the
expression pattern in the embryo, including expression in retina,
retinal pigment epithelium, pronephric ducts, liver, forebrain, gut,
blood vessels and cartilage. Thus our screening strategy has proven
an efﬁcient approach to enumerate the regulatory regions asso-
ciated with a complex expression pattern, over a large physical
segment of the genome. Importantly, only one of the functional
enhancers was identiﬁed by both VISTA and PhastCons. Addition-
ally, the two algorithms identiﬁed an overlapping pair of se-
quences, only the shorter one of which was a functional enhancer,
which suggests the presence of a negative regulatory element in
the longer sequence. These discrepancies highlight the impor-
tance of employing multiple approaches in comparative sequence
analysis.
We observed substantial overlap in function of the COL18A1
enhancer elements; most notably, all directed expression to cartilage,
although at varying levels and with different timing. The general
principle of multiple enhancer elements with overlapping function
has been observed previously for other genes with complex ex-
pression patterns (Antonellis et al., 2008; Pennacchio et al., 2006). In
the case of collagen XVIII, the biological signiﬁcance of expression in
cartilage is unclear, since Knobloch Syndrome patients do not have
any apparent cartilage phenotype.
The three splicing forms of COL18A1 show differential expression
in adult human tissues. In particular, the short form, transcribed from
the upstream promoter, is the predominant form in retina and kidney,
while the intermediate and long forms, transcribed from the down-
stream promoter, predominate in liver. Interestingly, our data reveals
transcriptional regulation that mirrors the tissue speciﬁc expression
pattern, with CNS −97.8/−96.9 regulating expression in retina and
Fig. 8. Identiﬁcation of an orthologous zebraﬁsh enhancer sequence showing functional overlap with CNSp+47.8 A) The intergenic sequence of COL18A1 encompassing CNSp+47.8
was compared to orthologous regions from mouse, stickleback, and zebraﬁsh, using Shufﬂe-Lagan. The turquoise line at top indicates the extent of the human enhancer element,
and blue the nearby coding exon, yellow blocks on the second line show the location of repetitive sequences. On the tracks for each species, colored peaks are those meeting the
criteria for conservation: turquoise aligning with the enhancer, red with other non-coding sequence, and blue with the exon. The analysis revealed alignment between the human
enhancer and zebraﬁsh non-coding sequence; the fragment indicated by the red bar was cloned as described in the text. Note that the larger alignment peak adjacent to the
cloned sequenced falls within repetitive sequence in both the human and zebraﬁsh genomes. The zebraﬁsh construct, zCNS +88, regulated EGFP expression in multiple embryonic
tissues, including B) heart and otic vesicle; C) aorta and ﬂoorplate (asterisk); cartilage (D, E); blood vessels of the pharyngeal arches (E, F); and cranial blood vessels (arrowheads
in G).
503E. Kague et al. / Developmental Biology 337 (2010) 496–505pronephric ducts, CNS +47.8 in retinal pigment epithelium, and CNS
+64.8 in liver. This suggests that speciﬁc enhancer elements interact
differentially with the two COL18A1 promoters.
We have previously demonstrated the utility of relying on
moderate levels of sequence conservation, i.e. among mammals, to
identify putative enhancer elements for in vivo testing (Fisher et al.,
2006a; Fisher et al., 2006b). In this study, although the algorithms
initially used did not detect non-coding conservation at the COL18A1locus from human to teleosts, the human sequences functioned
appropriately in zebraﬁsh transgenics. We could not unambiguously
identify conserved transcription factor binding sites by sequence
inspection, likely due to known variations in consensus sequences as
well as incomplete databases for binding sites. However, given the
conserved function of the human sequences in zebraﬁsh, the most
parsimonious explanation is that the same or related transcription
factors bind the orthologous elements in the two species, even in the
504 E. Kague et al. / Developmental Biology 337 (2010) 496–505cases where further analysis still failed to identify sequence con-
servation. Additional post hoc analysis did reveal detectable sequence
similarities in several regions between human and zebraﬁsh, although
these computational strategies would be difﬁcult to apply on a
genome-wide scale, or even at a single locus, with no prior knowledge
of functional enhancers. Following the post hoc analysis, we func-
tionally tested a zebraﬁsh sequence and demonstrated enhancer acti-
vity. We found substantial functional equivalence with the ortho-
logous human enhancer, including expression in blood vessels, a
biologically important site of type XVIII collagen action, and in cardiac
endoderm.
There are settings in which variations in expression levels or
patterns of COL18A1 may be clinically important, such as regulating
neovasculogenesis through the endostatin domain, and predisposi-
tion for obesity in diabetes type 2 and for hepatocarcinoma (Armelin-
Correa et al., 2005; Errera et al., 2008). Therefore, identiﬁcation of the
regulatory regions will provide insight into normal and pathogenic
regulation of COL18A1 expression.
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